Search Results for

Showing 1 - 4 of 4 results
  1. Spotlight on members: Spark

    Spotlight on members From hospital funding to FDA approval Spark Therapeutics develops gene therapy for inherited retinal blindness After over two decades of research and development in gene therapy, Katherine A. High, MD, co-founder, president and chief scientific officer of Spark Therapeutics, is breathing a big sigh of relief this fall. On Oct. 12, the Food and Drug Administration unanimously voted to approve voretigene neparvovec, Spark Therapeutics' gene therapy treatment for inherited b

  2. Statement for the Use of Animals in Ophthalmic and Vision Research

    Statement for the Use of Animals in Ophthalmic and Vision Research Introduction Guidelines for the design of experiments Guidelines for the conduct of experiments Factors that relate specifically to the conduct of vision and ophthalmology experiments Investigators outside the United States Animal use guidelines Alternatives to animal research Animal use resources Organizations that promote proper and ethical use of laboratory animals Introduction Research in vision and ophthalmology i

  3. Congressional briefing

    A Congressional briefing in Washington, D.C. highlighted how vision research pays for itself